Recombinant Cynomolgus CD24 Protein
Beta LifeScience
SKU/CAT #: BLK-02555P-100UG
Cynomolgus CD24 on Tris-Bis PAGE under reduced conditions. The purity is greater than 95%.
Recombinant Cynomolgus CD24 Protein
Beta LifeScience
SKU/CAT #: BLK-02555P-100UG
Collections: Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Cynomolgus CD24 Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Thr27-Lys54. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | I7GKK1 |
Target Symbol | CD24 |
Synonyms | CD 24; CD24 molecule; CD24A; FLJ22950; FLJ43543; MGC75043 |
Species | Cynomolgus |
Expression System | HEK293 |
Tag | C-hFc |
Expression Range | Thr27-Lys54 |
Mol. Weight | The protein has a predicted MW of 30.2 kDa. Due to glycosylation, the protein migrates to 45-60 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers. |